2009Chinese Journal of New Drugs and Clinical RemediesRequires access

Effects of esomeprazole combined with trimebutine in treatment for non-erosive reflux disease

Yanhong Shi, Liu Heng-lu, Zhanju Liu

Open publisher page 0 citations

Abstract

AIM To investigate the efficacy of esomeprazole combined with trimebutine in the treatment for non-erosive reflux disease (NERD). METHODS One hundred and sixty patients with NERD were randomly divided into 2 groups. The treatment group of 80 patients received esomeprazole 40 mg,qd combined with trimebutine 200 mg,tid; and the control group with another 80 patients had esomeprazole alone 40 mg,qd. The clinical efficacy was evaluated with a course of 8 weeks after the treatment according to measurement of reflux diagnostic questionnaire (RDQ). RESULTS The total effective rate in the treatment group was 94% ,while it was 80% in the control group; outcoming with significant difference between the two groups ( P 0.01); and with still more significant improvements of clinical symptoms in the treatment group (P 0.01). CONCLUSION Esomeprazole in combination with trimebutine is rather more helpful to provide the efficacy in treating NERD.

About this research paper

What this paper is about

AIM To investigate the efficacy of esomeprazole combined with trimebutine in the treatment for non-erosive reflux disease (NERD). METHODS One hundred and sixty patients with NERD were randomly divided into 2 groups. The treatment group of 80 patients received esomeprazole 40 mg,qd combined with trimebutine 200 mg,tid; and the control group with another 80 patients had esomeprazole alone 40 mg,qd. The clinical efficacy was evaluated with a course of 8 weeks after the treatment according to measurement of reflux diagnostic questionnaire (RDQ). RESULTS The total effective rate in the treatment group was 94% ,while it was 80% in the control group; outcoming with significant difference between the two groups ( P 0.01); and with still more significant improvements of clinical symptoms in the treatment group (P 0.01). CONCLUSION Esomeprazole in combination with trimebutine is rather more helpful to provide the efficacy in treating NERD.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

AIM To investigate the efficacy of esomeprazole combined with trimebutine in the treatment for non-erosive reflux disease (NERD). METHODS One hundred and sixty patients with NERD were randomly divided into 2 groups. The treatment group of 80 patients received esomeprazole 40 mg,qd combined with trimebutine 200 mg,tid; and the control group with another 80 patients had esomeprazole alone 40 mg,qd. The clinical efficacy was evaluated with a course of 8 weeks after the treatment according to measurement of reflux diagnostic questionnaire (RDQ). RESULTS The total effective rate in the treatment group was 94% ,while it was 80% in the control group; outcoming with significant difference between the two groups ( P 0.01); and with still more significant improvements of clinical symptoms in the treatment group (P 0.01). CONCLUSION Esomeprazole in combination with trimebutine is rather more helpful to provide the efficacy in treating NERD.

Key concepts: Esomeprazole, Nerd, Medicine, Reflux, Internal medicine, Gastroenterology, Clinical efficacy, Disease

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of esomeprazole combined with trimebutine in treatment for non-erosive reflux disease — Research Paper | ScholarLens